B-cell lymphoma medical therapy

Revision as of 02:26, 6 November 2017 by Mmir (talk | contribs) (Mahshid)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

B-cell lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating B-cell lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

B-cell lymphoma medical therapy On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of B-cell lymphoma medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on B-cell lymphoma medical therapy

CDC on B-cell lymphoma medical therapy

B-cell lymphoma medical therapy in the news

Blogs on B-cell lymphoma medical therapy

Directions to Hospitals Treating B-cell lymphoma

Risk calculators and risk factors for B-cell lymphoma medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Treatment

  • Treatment includes radiation and chemotherapy.
  • Early-stage indolent B-cell lymphomas can often be treated with radiation alone, with long-term non-recurrence.
  • Early-stage aggressive disease is treated with chemotherapy and often radiation, with a 70-90% cure rate.[1]
  • Late-stage indolent lymphomas are sometimes left untreated and monitored until they progress.
  • Late-stage aggressive disease is treated with chemotherapy, with cure rates of over 70%.[1]

References

  1. 1.0 1.1 Merck Manual home edition, Non-Hodgkin Lymphomas


Template:WikiDoc Sources